OrbiMed Capital GP V LLC, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), sold 21,400 shares at $1.96 ($42K) on 2020-12-08, disclosed to the SEC on 2020-12-10.
Open-market sale of $42k ARPO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| INSP | SELL | 2020-08-19 | $19.7M | — | Filing → |